找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Medical Imaging in Clinical Trials; Colin G. Miller,Joel Krasnow,Lawrence H. Schwartz Book 2014 Springer-Verlag London 2014 Ultrasonograph

[復(fù)制鏈接]
樓主: PED
51#
發(fā)表于 2025-3-30 10:31:28 | 只看該作者
The Metrics and New Imaging Marker Qualification in Medical Imaging Modalitiestic intervention. There are eight key metrics when evaluating a biomarker or imaging technique which has to be put into context with the key use of the system. This chapter will describe these key metrics in this context with particular emphasis of the use in clinical trials.
52#
發(fā)表于 2025-3-30 14:56:23 | 只看該作者
Radiation Risks and Dosimetry Assessmentnning stage and that the radiation risks are adequately explained as part of the informed consent process. It outlines the steps to take to assess the radiation dose, taking into account the potential variation between participating centres. It examines the risks associated with radiation exposure a
53#
發(fā)表于 2025-3-30 17:08:13 | 只看該作者
Imaging Review Charters and Operational Considerationsre are FDA guidelines (albeit in draft at the time of writing and presented verbatim in Appendix 1 of this book), which detail the requirements and contents for the Imaging Review Charter (IRC). This chapter provides the historical perspective for these guidelines and details the contents that have
54#
發(fā)表于 2025-3-30 23:19:40 | 只看該作者
Defining the Radiological Blinded Read and Adjudicationteam of radiologists and or physicians. There are three major kinds of blinded read: eligibility, safety, and efficacy, of which each of these is managed in a different manner. This chapter presents the various methodologies that are employed in blinded reads across phases of trials and between diff
55#
發(fā)表于 2025-3-31 02:53:15 | 只看該作者
56#
發(fā)表于 2025-3-31 08:50:55 | 只看該作者
Monitoring Responses to Therapy in Oncology trials. The fate of a new drug should not be wrongfully determined because of imprecise assessment methods used in the clinical trial. Therefore, it is crucial to select the most appropriate response assessment method, which considers the mechanisms of interactions between drugs and cancers as well
57#
發(fā)表于 2025-3-31 10:34:22 | 只看該作者
58#
發(fā)表于 2025-3-31 15:24:58 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-22 14:12
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
伽师县| 新津县| 同德县| 阿坝县| 哈巴河县| 太湖县| 肇州县| 梁河县| 仁布县| 青铜峡市| 潞西市| 阳信县| 九龙县| 湄潭县| 天峨县| 驻马店市| 永福县| 崇义县| 宁波市| 张家口市| 广灵县| 洛宁县| 南木林县| 阜新市| 老河口市| 安多县| 清徐县| 安吉县| 福安市| 读书| 建德市| 岳阳市| 三门峡市| 射洪县| 都兰县| 赫章县| 黄冈市| 乌兰浩特市| 广东省| 安远县| 乌鲁木齐县|